AETHLON MEDICAL INC (AEMD) Executive Compensation
AETHLON MEDICAL INC (AEMD) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AEMD
CIK: 882291
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 03/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 3/31/2025 12:00:00 AM
Lead Engagement PartnerWayne Pinnell
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-10-08 | 4 Filing | 0001683168-26-007901 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-09-30 | 4 Filing | 0001683168-26-007881 | View SEC Doc Filr Page |
| 4/A | 2026-10-15 | 2026-04-17 | 4/A Filing | 0001683168-26-007880 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-09-30 | 4 Filing | 0001683168-26-007879 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-09-30 | 4 Filing | 0001683168-26-007878 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-08 | 4 Filing | 0001683168-26-007822 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0001595888-26-000121 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-07 | FORM 8-K | 0001683168-26-007749 | View SEC Doc Filr Page |
| 8-K/A | 2026-10-05 | 2026-10-01 | FORM 8-K AMENDMENT | 0001683168-26-007613 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-10-01 | CURRENT REPORT | 0001683168-26-007542 | View SEC Doc Filr Page |
| 425 | 2026-09-17 | — | FORM 8-K | 0001683168-26-007208 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-17 | FORM 8-K | 0001683168-26-007206 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-11 | CURRENT REPORT | 0001683168-26-007126 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-04 | — | FORM DEFA14A | 0001683168-26-006969 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-01 | 2026-10-01 | DEFINITIVE PROXY | 0001683168-26-006844 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-28 | CURRENT REPORT | 0001683168-26-006815 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-21 | 2026-10-01 | PRELIMINARY PROXY STATEMENT | 0001683168-26-006654 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006347 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | CURRENT REPORT | 0001683168-26-006344 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088823 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-30 | CURRENT REPORT | 0001683168-26-005850 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-06 | CURRENT REPORT | 0001683168-26-005338 | View SEC Doc Filr Page |
| 424B3 | 2026-07-07 | — | PROSPECTUS | 0001683168-26-005322 | View SEC Doc Filr Page |
| EFFECT | 2026-07-06 | — | EFFECT Filing | 9999999995-26-002203 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001683168-26-005226 | View SEC Doc Filr Page |